Sharon Hemond Hrynkow
CIK 1745677 · Chief Scientific Officer · last filed 2025-09-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
18
Lifetime Open-Market Net
$23.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Forward Industries, Inc. (FORD) Delisted | Director | 10,000 | $9.48 | $94.8K | $11.3K | 7 | 2025-09-11 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Chief Scientific Officer | 19,350 | $0.03 | $619 | $12.4K | 5 | 2021-12-02 |
Recent Filings · Page 2 of 2
18 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-25 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2020-12-14 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Mixed | +1,000 | $0 | EDGAR |
| 2020-04-27 | — | Grant (A) | +200,000 | $20.0K | |
| 2019-09-30 | — | Grant (A) | +100,000 | $0 | |
| 2019-08-02 | — | Buy (P) | +10,000 | $2.5K | |
| 2019-07-31 | — | Buy (P) | +10,000 | $2.4K | |
| 2019-06-03 | — | Buy (P) | +40,000 | $0 | |
| 2018-12-27 | — | Buy (P) | +40,000 | $0 |
Showing 11–18 of 18
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.